TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-09
DOI
10.1038/s41598-019-49390-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation
- (2018) Gail A. Bishop et al. Frontiers in Immunology
- Genetic Alterations of TRAF Proteins in Human Cancers
- (2018) Sining Zhu et al. Frontiers in Immunology
- TRAF3 as a powerful and multitalented regulator of lymphocyte functions
- (2016) Gail A. Bishop JOURNAL OF LEUKOCYTE BIOLOGY
- Nuclear TRAF3 is a negative regulator of CREB in B cells
- (2016) Nurbek Mambetsariev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TRAF3 deficiency promotes metabolic reprogramming in B cells
- (2016) Nurbek Mambetsariev et al. Scientific Reports
- Introduction to a series of reviews on multiple myeloma
- (2015) J. F. San Miguel BLOOD
- Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer
- (2015) Nizam Uddin et al. CANCER SCIENCE
- Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
- (2015) R. Pagliarini et al. EMBO REPORTS
- Conditional Deletion of NF-κB–Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation
- (2015) Hans D. Brightbill et al. JOURNAL OF IMMUNOLOGY
- The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development
- (2015) Wai W. Lin et al. Science Signaling
- MYC Alterations in Diffuse Large B-Cell Lymphomas
- (2015) Kennosuke Karube et al. SEMINARS IN HEMATOLOGY
- Targeting the Pim kinases in multiple myeloma
- (2015) N A Keane et al. Blood Cancer Journal
- An Oncogenic Role for Alternative NF-κB Signaling in DLBCL Revealed upon Deregulated BCL6 Expression
- (2015) Baochun Zhang et al. Cell Reports
- The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development
- (2015) Wai W. Lin et al. Science Signaling
- Genetic inactivation of TRAF3 in canine and human B-cell lymphoma
- (2014) K. R. Bushell et al. BLOOD
- Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B-cell Lymphoma
- (2014) S. E. Trabucco et al. CLINICAL CANCER RESEARCH
- Pim kinases in hematological malignancies: where are we now and where are we going?
- (2014) Patrizia Mondello et al. Journal of Hematology & Oncology
- Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin
- (2014) Samik Basu et al. JOURNAL OF IMMUNOLOGY
- Myeloid Cell TRAF3 Regulates Immune Responses and Inhibits Inflammation and Tumor Development in Mice
- (2014) Almin I. Lalani et al. JOURNAL OF IMMUNOLOGY
- Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma
- (2014) M Affer et al. LEUKEMIA
- The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2
- (2014) Zuoan Yi et al. NATURE IMMUNOLOGY
- C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies
- (2014) Kuangguo Zhou et al. PLoS One
- A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas
- (2014) Jason M. Foulks et al. NEOPLASIA
- Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation
- (2013) J. Lu et al. BLOOD
- An Efficient Low Cost Method for Gene Transfer to T Lymphocytes
- (2013) Leonardo Chicaybam et al. PLoS One
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification
- (2013) G. Ott et al. Hematology-American Society of Hematology Education Program
- A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes
- (2013) Wai W. Lin et al. Frontiers in Immunology
- Addiction to c-MYC in multiple myeloma
- (2012) T. Holien et al. BLOOD
- PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
- (2011) C. Gomez-Abad et al. BLOOD
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice
- (2011) C R Moore et al. LEUKEMIA
- The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
- (2011) J Asano et al. LEUKEMIA
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNF Receptor-Associated Factor 3 Is Required for T Cell-Mediated Immunity and TCR/CD28 Signaling
- (2010) P. Xie et al. JOURNAL OF IMMUNOLOGY
- Oncogenic Activation of NF- B
- (2010) L. M. Staudt Cold Spring Harbor Perspectives in Biology
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
- (2009) L. S. Chen et al. BLOOD
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- TRAF2 and TRAF3 Signal Adapters Act Cooperatively to Control the Maturation and Survival Signals Delivered to B Cells by the BAFF Receptor
- (2008) Sandra Gardam et al. IMMUNITY
- Pim kinase-dependent inhibition of c-Myc degradation
- (2008) Y Zhang et al. ONCOGENE
- Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
- (2007) R. T. Woodland et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started